Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Commentary

Quality improvement initiative to decrease central line-associated bloodstream infections during the COVID-19 pandemic: a "zero harm" approach.

Redstone CS, Zadeh M, Wilson M-A, et al. Quality improvement initiative to decrease central line-associated bloodstream infections during the COVID-19 pandemic: a "zero harm" approach. J Patient Saf. 2023;19(3):173-179. doi:10.1097/pts.0000000000001107.

Save
Print
April 19, 2023
Redstone CS, Zadeh M, Wilson M-A, et al. J Patient Saf. 2023;19(3):173-179.
View more articles from the same authors.

Previous research has found that central line-associated blood stream infections (CLABSIs) increased during the COVID-19 pandemic. This article describes the development, implementation, and evaluation of a quality improvement initiative (QI) at one community health system in Canada to reduce CLABSIs between July 2019 and May 2022. The QI initiative included changes in six areas – organizational oversight and accountability, education and training, standardized central line processes, optimized central line equipment, improving data and reporting, and fostering a culture of safety. Over the study period, CLABSIs were reduced by 51% and the use of both central line insertion checklists and central line capped lumens increased.

Save
Print
Cite
Citation

Redstone CS, Zadeh M, Wilson M-A, et al. Quality improvement initiative to decrease central line-associated bloodstream infections during the COVID-19 pandemic: a "zero harm" approach. J Patient Saf. 2023;19(3):173-179. doi:10.1097/pts.0000000000001107.